Patent · US Active

Sulphimides as protein kinase inhibitors

US7943629B2 · kind B2 · utility

10Cited by

0References

24Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Ulrich Luecking · Berlin, DE
Duy Nguyen · Berlin, DE
Arne Von Bonin · Hohen Neuendorf, DE
Oliver von Ahsen · Berlin, DE
Gerhard Siemeister · Berlin, DE
Rolf Jautelat · Haan, DE
Wolf-Dietrich Doecke · Berlin, DE

Key dates

Filing date	Jun 7, 2007
Grant date	May 17, 2011
Priority date	—
Expiry date	Mar 4, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/48
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to sulphimides as protein kinase inhibitors of the general formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.